VRIDABI 110 CAPSULE
Generic Salt Composition: Dabigatran Etexilate 110mg
Price: ₹132 MRP: ₹271.88
Save up to 51% compared to branded medicines.
Top Brand Substitutes & Equivalents
Pradaxa, Dabigza, Dabistar, Dabiclot, Afibigatran, Dabigrel, Tromboclot, Dabigard, Dabiflo, Dabix, Dabistop, Dabiprex, Dabifree, Dabisafe, Dabicheck, Dabirisk, Dabiprotect, Dabistroke, Dabifast, Dabimain, Dabigatran Sun Pharma, Sun Pharma Dabigatran, Dabigatran Cipla, Cipla Dabigatran, Dabigatran Dr Reddys, Dr Reddys Dabigatran, Dabigatran Lupin, Lupin Dabigatran, Dabigatran Torrent, Torrent Dabigatran
Product Overview & Uses
VRIDABI 110 CAPSULE is a high-efficacy anticoagulant medication containing Dabigatran Etexilate 110mg. It is a cornerstone therapy in the Blood Pressure & Heart category for patients requiring long-term management of thromboembolic disorders. Unlike traditional vitamin K antagonists, VRIDABI 110 CAPSULE offers a predictable pharmacokinetic profile, reducing the need for routine coagulation monitoring. It is specifically designed to inhibit thrombin, the enzyme responsible for converting fibrinogen into fibrin, which is the final step in the blood clotting cascade. By preventing this conversion, VRIDABI 110 CAPSULE effectively reduces the risk of stroke in patients with non-valvular atrial fibrillation. Furthermore, it is indicated for the treatment of acute deep vein thrombosis and pulmonary embolism, providing a reliable alternative to injectable anticoagulants. Patients prescribed VRIDABI 110 CAPSULE must adhere strictly to the dosage regimen to maintain therapeutic levels and minimize the risk of bleeding complications. Regular consultation with a healthcare provider is essential when using this medication within the Blood Pressure & Heart category to ensure safety and efficacy throughout the treatment duration.